Lacutamab Biosimilar(Anti-KIR3DL2 / CD158k Reference Antibody) Datasheet DC Chemicals
Description
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma.